Seminar "Pricing policies and other strategies to improve access to medicines"
The Department of Health Systems and Services, Medicines and Health Technologies Unit of the Pan American Health Organization organizes the Seminar Pricing Policies and other Strategies to Improve Access to Medicines. The central conference will be led by Professor Panos Kanavos of the London School of Economics and Political Science (LSE).
The Seminar will be held on January 22 at 10:30 am, Wahington, DC time.
Those interested can attend the same via WebEx using the following link: https://paho.webex.com/meet/hta.
Presentations will be in English and there will be no translation.
Agenda – January 22
10:30 Opening remarks (Isabella Danel – Deputy Director PAHO)
10:45 -12: 15
Moderator: James Fitzgerald – HSS Director
Introduction: Analía Porrás (Head of Unit – HSS / MT)
Conference: Panos Kanavos (Deputy Director – LSE Health)
Comments: Amanda Glassman (Director of Global Health Policy – Center for Global Development)
12: 15-13: 00 Discussion
Panos Kanavos (BSc, MSc, PhD) is Professor of International Health Policy at the Department of Social Policy at the London School of Economics (LSE) and Program Director of the Medical Research Technology Group (MTRG) ) At LSE Health. He was a Harkness Fellow in Health Care Policy at the Department of Ambulatory Care and Prevention, Harvard Medical School. She is an economist by profession, currently coordinates the Program on International Health Policies at the LSE and teaches Health Economics, Pharmaceutical Economics and Policy, Health System Finance, and Health System Performance Indicators.
Panos Kanavos led the activities of MTRG, which is a research unit comprising 11 researchers at LSE Health, focusing on interdisciplinary and comparative research of medical technology policies. The group follows the following research currents:
– The economics of medical technologies, in particular drugs and medical devices;
– Prescription, relevance and quality of care;
– Access to developing medical technologies and economies in transition; Y
– Management of disease and the effectiveness of policies in medical technology.
As part of its activities, MTRG administers the Program on Pharmaceutical Policy Issues (PPPI), the Medical Devices Program, participates in and conducts studies sponsored by the European Medicines Information Network (EMI) -net, participates in the network for the study of rare diseases (BURQOL-RD), and is a member of the European Institute of Health Technology for Socio-economic Research (EHTI, for its acronym in English). It also coordinates the activities of the Patient Academy, an initiative between academia, health care regulatory agencies and patient groups.
Panos Kanavos has served as an advisor to a number of international governmental and non-governmental organizations, including the European Commission, the European Parliament, the World Bank, the World Health Organization, the Organization for Economic Co-operation and Development, the American Returnees and ministries of health in more than 21 countries in transition and in development. He has participated in the European Forum of Pharmacists as an advisor to the European Commission – Directorate-General for Enterprise and was part of the Commission’s reflection process on the economic aspects of medical devices.
Amanda Glassman is the program vice president, global health policy director, and senior fellow at the Center for Global Development, leading work on prioritization, resource allocation and value-for-money relation in global health, with a particular interest in vaccination. He has 20 years of experience working on health and social protection policies and programs in Latin America and other developing countries. Prior to her current position, Amanda Glassman served as technical director for health at the Inter-American Development Bank (IDB), where she led health economics and knowledge finance products and political dialogue with member countries, designed the grant program Based on “Salud Mesoamérica 2015” and served as team leader for conditional transfer programs such as Oportunidades de México and Colombia Familias en Acción.
Since 2005-2007, Amanda Glassman has been the associate director of the Global Health Financing Initiative in Brookings and has conducted research on health care effectiveness and domestic financial policies in low-income countries. Prior to joining the Brookings Institution, Amanda Glassman designed, supervised and evaluated health and social protection loans at the IDB and worked as a Population Reference Bureau Fellow at the United States Agency for International Development. She holds a master’s degree from the Harvard School of Public Health and is a graduate of Brown University.